Search research articles
Contact Us
Filters
Showing results (291-300 of 560) with videos related to
Page
of 56
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 19, 2025
Impact of anthracyclines in genomic high-risk, node-negative, HR-positive/HER2-negative breast cancer
N Chen, J Q Freeman, S Yarlagadda, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
|
June 22, 2012
Prognostic significance of serial postoperative EEG in extratemporal lobe epilepsy surgery
Giancarlo Di Gennaro, Marco De Risi, Pier Paolo Quarato, et al.
The Oncologist
|
April 16, 2022
Safety and Tolerability of Carboplatin and Paclitaxel in Cancer Patients with HIV (AMC-078), an AIDS Malignancy Consortium (AMC) Study
Missak Haigentz, Page Moore, Milan Bimali, et al.
Gynecologic Oncology
|
September 15, 2010
Erlotinib added to carboplatin and paclitaxel as first-line treatment of ovarian cancer: a phase II study based on surgical reassessment
Stephanie V Blank, Paul Christos, John P Curtin, et al.
Maternal and Child Health Journal
|
September 15, 2012
Being macrosomic at birth is an independent predictor of overweight in children: results from the IDEFICS study
Sonia Sparano, Wolfgang Ahrens, Stefaan De Henauw, et al.
Endocrine
|
January 26, 2025
Pros and cons of surgical versus conservative management for head and neck paraganglioma: a real-world data analysis
L Canu, L Zanatta, C Sparano, et al.
European Journal of Neurology
|
April 29, 2006
Lateralizing value of memory tests in drug-resistant temporal lobe epilepsy
L G Grammaldo, T Giampà, P P Quarato, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 2, 2010
Phase I trial of ixabepilone plus pegylated liposomal doxorubicin in patients with adenocarcinoma of breast or ovary
E Chuang, N Wiener, P Christos, et al.
Leukemia & Lymphoma
|
July 1, 1994
Infusional cyclophosphamide, doxorubicin and etoposide in HIV-related non-Hodgkin's lymphoma: a follow-up report of a highly active regimen
J A Sparano, P H Wiernik, M Strack, et al.
NPJ Breast Cancer
|
January 23, 2018
E2112: randomized phase iii trial of endocrine therapy plus entinostat/placebo in patients with hormone receptor-positive advanced breast cancer
Sri Lakshmi Hyndavi Yeruva, Fengmin Zhao, Kathy D Miller, et al.
Page
of 56
Search research articles
Search
Showing results (291-300 of 560) with videos related to
Sort By:
Page
of 56
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 19, 2025
Impact of anthracyclines in genomic high-risk, node-negative, HR-positive/HER2-negative breast cancer
N Chen, J Q Freeman, S Yarlagadda, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
|
June 22, 2012
Prognostic significance of serial postoperative EEG in extratemporal lobe epilepsy surgery
Giancarlo Di Gennaro, Marco De Risi, Pier Paolo Quarato, et al.
The Oncologist
|
April 16, 2022
Safety and Tolerability of Carboplatin and Paclitaxel in Cancer Patients with HIV (AMC-078), an AIDS Malignancy Consortium (AMC) Study
Missak Haigentz, Page Moore, Milan Bimali, et al.
Gynecologic Oncology
|
September 15, 2010
Erlotinib added to carboplatin and paclitaxel as first-line treatment of ovarian cancer: a phase II study based on surgical reassessment
Stephanie V Blank, Paul Christos, John P Curtin, et al.
Maternal and Child Health Journal
|
September 15, 2012
Being macrosomic at birth is an independent predictor of overweight in children: results from the IDEFICS study
Sonia Sparano, Wolfgang Ahrens, Stefaan De Henauw, et al.
Endocrine
|
January 26, 2025
Pros and cons of surgical versus conservative management for head and neck paraganglioma: a real-world data analysis
L Canu, L Zanatta, C Sparano, et al.
European Journal of Neurology
|
April 29, 2006
Lateralizing value of memory tests in drug-resistant temporal lobe epilepsy
L G Grammaldo, T Giampà, P P Quarato, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 2, 2010
Phase I trial of ixabepilone plus pegylated liposomal doxorubicin in patients with adenocarcinoma of breast or ovary
E Chuang, N Wiener, P Christos, et al.
Leukemia & Lymphoma
|
July 1, 1994
Infusional cyclophosphamide, doxorubicin and etoposide in HIV-related non-Hodgkin's lymphoma: a follow-up report of a highly active regimen
J A Sparano, P H Wiernik, M Strack, et al.
NPJ Breast Cancer
|
January 23, 2018
E2112: randomized phase iii trial of endocrine therapy plus entinostat/placebo in patients with hormone receptor-positive advanced breast cancer
Sri Lakshmi Hyndavi Yeruva, Fengmin Zhao, Kathy D Miller, et al.
Page
of 56